GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Other Current Receivables

Gemina Laboratories (XCNQ:GLAB) Other Current Receivables : C$0.04 Mil (As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories Other Current Receivables?

Gemina Laboratories's Other Current Receivables for the quarter that ended in Jan. 2024 was C$0.04 Mil.

Gemina Laboratories's quarterly Other Current Receivables declined from Jul. 2023 (C$0.22 Mil) to Oct. 2023 (C$0.19 Mil) but then stayed the same from Oct. 2023 (C$0.19 Mil) to Jan. 2024 (C$0.04 Mil).

Gemina Laboratories's annual Other Current Receivables increased from Jan. 2022 (C$0.19 Mil) to Jan. 2023 (C$0.39 Mil) but then declined from Jan. 2023 (C$0.39 Mil) to Jan. 2024 (C$0.04 Mil).

Gemina Laboratories Other Current Receivables Historical Data

The historical data trend for Gemina Laboratories's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Other Current Receivables Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Other Current Receivables
- 0.19 0.39 0.04

Gemina Laboratories Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.44 0.22 0.19 0.04

Gemina Laboratories Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Gemina Laboratories Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Gemina Laboratories (XCNQ:GLAB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Other Current Receivables
Comparable Companies
TSX:ATE TSXV:GSD TSX:MBX TSX:TH TSXV:TTI XCNQ:ACOG TSXV:MSCL TSXV:COV TSX:APS TSXV:CZO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
GLABF:USA
Address
3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Website
https://www.geminalabs.com
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.
Executives
James Damian Tansey Director

Gemina Laboratories (XCNQ:GLAB) Headlines

No Headlines